Alnylam Pharmaceuticals, Inc.

BANK OF MONTREAL /CAN/ ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

35,116

Value ($000)

13,964

Weight

0.0%

2013 Q3 - 2025 Q4 (28 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	13,964	0.0%	35,116	12/31/2025
2025 Q3	11/13/2025	4,529	0.0%	9,933	9/30/2025
2025 Q2	8/5/2025	4,275	0.0%	13,111	6/30/2025
2025 Q1	5/13/2025	2,885	0.0%	10,684	3/31/2025
2024 Q4	2/13/2025	2,731	0.0%	11,607	12/31/2024
2024 Q3	11/13/2024	5,991	0.0%	21,791	9/30/2024
2024 Q2	8/14/2024	7,660	0.0%	31,176	6/30/2024
2024 Q1	5/13/2024	15,887	0.0%	102,508	3/31/2024
2023 Q4	2/8/2024	7,873	0.0%	39,965	12/31/2023
2023 Q3	11/1/2023	8,963	0.0%	48,203	9/30/2023
2023 Q2	8/2/2023	12,182	0.0%	59,504	6/30/2023
2023 Q1	6/13/2024	11,573	0.0%	57,728	3/31/2023
2022 Q4	2/1/2023	5,729	0.0%	24,068	12/31/2022
2022 Q3	11/10/2022	12,269	0.0%	58,149	9/30/2022
2022 Q2	8/11/2022	11,218	0.0%	77,081	6/30/2022
2022 Q1	5/12/2022	12,433	0.0%	73,751	3/31/2022
2021 Q4	2/11/2022	6,850	0.0%	39,484	12/31/2021
2021 Q3	11/12/2021	9,522	0.0%	53,341	9/30/2021
2021 Q2	8/12/2021	7,111	0.0%	42,751	6/30/2021
2021 Q1	5/13/2021	6,011	0.0%	42,183	3/31/2021
2020 Q4	2/12/2021	7,071	0.0%	45,145	12/31/2020
2020 Q3	11/12/2020	7,893	0.0%	55,100	9/30/2020
2020 Q2	8/12/2020	10,309	0.0%	64,824	6/30/2020
2020 Q1	5/13/2020	6,573	0.0%	63,079	3/31/2020
2019 Q4	2/10/2020	6,732	0.0%	58,457	12/31/2019
2014 Q1	5/15/2014	13	0.0%	189	3/31/2014
2013 Q4	1/8/2014	12	0.0%	189	12/31/2013
2013 Q3	1/8/2014	12	0.0%	189	9/30/2013